1497TiP REACTION – a phase Ib pilot study of nivolumab or nivolumab in combination with relatlimab after targeted radiation in patients with advanced esophagogastric cancer
Lam, V.K., Hales, R., Feliciano, J.L., Voong, K.R., Shin, E., Smith, K., Anagnostou, V., Velculescu, V., Thompson, E., Sears, C., Pardoll, D., Rodavia, H., Schneider, H., Hu, C., Amjad, A., Guerrieri, P., Jobe, B.A., Zaidi, A.H., Kelly, R.J.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article